Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France? - Université de Rennes Accéder directement au contenu
Article Dans Une Revue Infectious Diseases Now Année : 2021

Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France?

Dates et versions

hal-03367942 , version 1 (06-10-2021)

Identifiants

Citer

Christele Gras-Le Guen, Nicolas Vignier, Fabienne Kochert, Etienne Javouhey, Emma Allain Launay, et al.. Why should the meningococcal B vaccine be recommended, and therefore reimbursed, for infants in France?. Infectious Diseases Now, 2021, 51 (5), pp.407-409. ⟨10.1016/j.idnow.2021.05.001⟩. ⟨hal-03367942⟩
24 Consultations
0 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More